Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Common Equity (2016 - 2025)

Historic Common Equity for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $300.0 million.

  • Chemours' Common Equity fell 5348.84% to $300.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.0 million, marking a year-over-year decrease of 5348.84%. This contributed to the annual value of $588.0 million for FY2024, which is 2032.52% down from last year.
  • As of Q3 2025, Chemours' Common Equity stood at $300.0 million, which was down 5348.84% from $239.0 million recorded in Q2 2025.
  • Chemours' 5-year Common Equity high stood at $1.3 billion for Q3 2022, and its period low was $239.0 million during Q2 2025.
  • Over the past 5 years, Chemours' median Common Equity value was $810.0 million (recorded in 2023), while the average stood at $839.7 million.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 3697.18% in 2022, then tumbled by 6662.01% in 2025.
  • Over the past 5 years, Chemours' Common Equity (Quarter) stood at $1.1 billion in 2021, then increased by 2.31% to $1.1 billion in 2022, then crashed by 33.33% to $738.0 million in 2023, then fell by 20.33% to $588.0 million in 2024, then tumbled by 48.98% to $300.0 million in 2025.
  • Its Common Equity was $300.0 million in Q3 2025, compared to $239.0 million in Q2 2025 and $580.0 million in Q1 2025.